BI Logo 385 12.5/2.5 Pill - red elliptical/oval
Generic Name: empagliflozin/linagliptin/metformin
Pill with imprint BI Logo 385 12.5/2.5 is Red, Elliptical/Oval and has been identified as Trijardy XR empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release. It is supplied by Boehringer Ingelheim and Eli Lilly and Company.
Trijardy XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Trijardy XR empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release is not a controlled substance under the Controlled Substances Act (CSA).
Images for BI Logo 385 12.5/2.5
Trijardy XR
- Generic Name
- empagliflozin/linagliptin/metformin
- Imprint
- BI Logo 385 12.5/2.5
- Strength
- empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release
- Color
- Red
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim and Eli Lilly and Company
- National Drug Code (NDC)
- 00597-0385
More about Trijardy XR (empagliflozin / linagliptin / metformin)
Check interactions
Compare alternatives
Pricing & coupons
Drug images
Latest FDA alerts (5)
Side effects
Dosage information
During pregnancy
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.